Cover Image

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

NMDARs (N-methyl-D-aspartate receptors) have long been known for their role in neuropathology, and inappropriate activity is implicated in neuronal loss in acute disorders such as stroke and traumatic brain injury. Certain chronic neurodegenerative diseases are also associated with abnormal NMDAR ac...

Full description

Saved in:
Bibliographic Details
Main Authors: Hardingham, Giles E. (Author) , Bading, Hilmar (Author)
Format: Article (Journal)
Language:English
Published: [October 2010]
In: Nature reviews. Neuroscience
Year: 2010, Volume: 11, Issue: 10, Pages: 682-696
ISSN:1471-0048
DOI:10.1038/nrn2911
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/nrn2911
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/nrn2911
Get full text
Author Notes:Giles E. Hardingham and Hilmar Bading

MARC

LEADER 00000caa a2200000 c 4500
001 1838563989
003 DE-627
005 20230710153343.0
007 cr uuu---uuuuu
008 230308s2010 xx |||||o 00| ||eng c
024 7 |a 10.1038/nrn2911  |2 doi 
035 |a (DE-627)1838563989 
035 |a (DE-599)KXP1838563989 
035 |a (OCoLC)1389821064 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hardingham, Giles E.  |e VerfasserIn  |0 (DE-588)116404897X  |0 (DE-627)1028416989  |0 (DE-576)508350646  |4 aut 
245 1 0 |a Synaptic versus extrasynaptic NMDA receptor signalling  |b implications for neurodegenerative disorders  |c Giles E. Hardingham and Hilmar Bading 
264 1 |c [October 2010] 
300 |b Illustrationen 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online 15 September 2010 
500 |a Gesehen am 08.03.2023 
520 |a NMDARs (N-methyl-D-aspartate receptors) have long been known for their role in neuropathology, and inappropriate activity is implicated in neuronal loss in acute disorders such as stroke and traumatic brain injury. Certain chronic neurodegenerative diseases are also associated with abnormal NMDAR activity, including Huntington's and Alzheimer's diseases. However, the destructive effects of NMDAR activity are in striking contrast to the observation that the survival and resistance to trauma of several neuronal types is boosted by physiological synaptic NMDAR activity and function. Thus, there is a dichotomy of NMDAR signalling.Recent studies have shown that cellular responses to NMDAR activation can depend on the receptor location. Activation of synaptic NMDARs, particularly when activated trans-synaptically, promotes neuronal health, whereas chronic activation of extrasynaptic NMDARs couples to cell death pathways. Differences are observed even when the overall Ca2+ loads triggered via the two routes are similar.Synaptic NMDAR activity strongly promotes neuronal health by initiating a programme of transcriptional changes that promote resistance to various traumatic stimuli. Synaptic NMDARs control a nuclear Ca2+-regulated multi-gene program that protects against excitotoxic and apoptotic insults. Transcriptional suppression of key components of the intrinsic apoptosis pathway also restricts the apoptotic potential of neurons. Moreover, synaptic NMDAR activity promotes resistance to oxidative insults by boosting intrinsic antioxidant defences through transcriptional changes of proteins encoding antioxidant genes and regulatory factors.Extrasynaptic NMDAR activity is coupled to several signalling pathways that promote neuronal death or vulnerability to trauma. These include the dephosphorylation and inactivation of the pro-survival transcription factor cyclic-AMP response element binding protein (CREB), nuclear import of the pro-death transcription factor forkhead box protein O (FOXO), inactivation of extracellular signal-regulated kinase 1/2 (ERK1/2) mitogen-activated protein (MAP) kinase, and calpain-dependent striatal enriched tyrosine phosphatase (STEP) cleavage and activation of p38 MAP kinase.A shift in the balance from synaptic towards extrasynaptic NMDAR signalling may be an important factor in the aetiology of neurodegenerative diseases. In Huntington's disease, mutant huntingtin causes a specific increase in extrasynaptic NMDAR currents. Furthermore, extrasynaptic NMDAR activity in turn promotes the toxicity of mutant huntingtin and synaptic NMDAR activity reduces mutant huntingtin toxicity by promoting the formation of non-toxic inclusions. In acute ischaemic trauma, cell death may be caused in part by an upregulation and activation of extrasynaptic NMDARsIn treating disorders associated with abnormal NMDAR activity, therapies aimed at selectively blocking chronic extrasynaptic NMDAR activity without interfering with normal synaptic NMDAR activity may be better tolerated and more efficacious than conventional antagonists. The NMDAR antagonist memantine is well suited to this role, which may explain its tolerance in humans and its recently demonstrated efficacy in preclinical models of Huntington's disease. 
650 4 |a Cell signalling 
650 4 |a Huntington's disease 
700 1 |a Bading, Hilmar  |d 1958-  |e VerfasserIn  |0 (DE-588)1017989680  |0 (DE-627)690486553  |0 (DE-576)170837947  |4 aut 
773 0 8 |i Enthalten in  |t Nature reviews. Neuroscience  |d London : Nature Publ. Group, 2000  |g 11(2010), 10 vom: Okt., Seite 682-696  |h Online-Ressource  |w (DE-627)324614748  |w (DE-600)2028902-9  |w (DE-576)100357903  |x 1471-0048  |7 nnas  |a Synaptic versus extrasynaptic NMDA receptor signalling implications for neurodegenerative disorders 
773 1 8 |g volume:11  |g year:2010  |g number:10  |g month:10  |g pages:682-696  |g extent:15  |a Synaptic versus extrasynaptic NMDA receptor signalling implications for neurodegenerative disorders 
856 4 0 |u https://doi.org/10.1038/nrn2911  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/nrn2911  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230308 
993 |a Article 
998 |g 1017989680  |a Bading, Hilmar  |m 1017989680:Bading, Hilmar  |d 700000  |d 712000  |d 712100  |e 700000PB1017989680  |e 712000PB1017989680  |e 712100PB1017989680  |k 0/700000/  |k 1/700000/712000/  |k 2/700000/712000/712100/  |p 2  |y j 
999 |a KXP-PPN1838563989  |e 428467305X 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"disp":"Synaptic versus extrasynaptic NMDA receptor signalling implications for neurodegenerative disordersNature reviews. Neuroscience","physDesc":[{"extent":"Online-Ressource"}],"recId":"324614748","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 31.07.2018"],"title":[{"partname":"Neuroscience","title_sort":"Nature reviews","title":"Nature reviews"}],"origin":[{"dateIssuedDisp":"2000-","dateIssuedKey":"2000","publisherPlace":"London","publisher":"Nature Publ. Group"}],"id":{"eki":["324614748"],"issn":["1471-0048"],"zdb":["2028902-9"]},"part":{"volume":"11","year":"2010","extent":"15","text":"11(2010), 10 vom: Okt., Seite 682-696","issue":"10","pages":"682-696"},"pubHistory":["1.2000 -"],"titleAlt":[{"title":"Nature reviews / Neuroscience"}]}],"person":[{"family":"Hardingham","role":"aut","given":"Giles E.","display":"Hardingham, Giles E."},{"display":"Bading, Hilmar","given":"Hilmar","role":"aut","family":"Bading"}],"origin":[{"dateIssuedDisp":"[October 2010]","dateIssuedKey":"2010"}],"note":["Published online 15 September 2010","Gesehen am 08.03.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"subtitle":"implications for neurodegenerative disorders","title_sort":"Synaptic versus extrasynaptic NMDA receptor signalling","title":"Synaptic versus extrasynaptic NMDA receptor signalling"}],"physDesc":[{"extent":"15 S.","noteIll":"Illustrationen"}],"recId":"1838563989","name":{"displayForm":["Giles E. Hardingham and Hilmar Bading"]},"id":{"doi":["10.1038/nrn2911"],"eki":["1838563989"]}} 
SRT |a HARDINGHAMSYNAPTICVE2010 

Similar Items